Merck has signed a landmark voluntary licensing deal with the UN-backed Medicines Patent Pool to expand low-cost access to its Covid-19 antiviral pill throughout the developing world.
默克(Merk)與聯(lián)合國(UN)支持的“藥物專利池”(Medicines Patent Pool)簽署了一項具有里程碑意義的自愿許可協(xié)議，以擴大其新冠抗病毒藥物在整個發(fā)展中國家的低成本獲取。
您已閱讀6%（278字），剩余94%（4364字）包含更多重要信息，訂閱以繼續(xù)探索完整內容，并享受更多專屬服務。